Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

KING SYSTEMS CORPORATION.

US

Last updated September 17, 2026

Information

Country
US
Address
15011 HERRIMAN BLVD., Noblesville, IN, 46060
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
1824226
DUNS Number
—

Catalogue (1113)

Page 9 of 23
DeviceModel / ReferenceRegistriesClassStatus
Ped F2® Pediatricanesthesia Breathing Circuit F90628
FDA UDI
Class IActive
Universal F2®anesthesia Breathing Circuit D365-6121Z
FDA UDI
Class IActive
Universal Flex2®breathing Circuit KNCF375V-6121Z
FDA UDI
Class IActive
Pediatric Ultra Flex® 2616P-136
FDA UDI
Class IActive
Pediatric Ultra Flex® 21216P-19021
FDA UDI
Class IActive
Universal F2®anesthesia Breathing Circuit D360-325Z
FDA UDI
Class IUnknown
Adult Ultra Flex® 81810B-06
FDA UDI
Class IActive
Breathing Bag 5109
FDA UDI
Class IActive
Universal Flex2® XF75
FDA UDI
Class IActive
Adult Ultra Flex®anesthesia Breathing Circuit 8753F-6121Z
FDA UDI
Class IActive
Adult Anesthesiabreathing Circuit 6603F-6121Z
FDA UDI
Class IUnknown
Adult Ultra Flex® 6752BF-13221
FDA UDI
Class IActive
Disposable Xenon Circuitfor Nuclear Medicine D062
FDA UDI
Class IIActive
Universal Flex2®breathing Circuit & Pack Kit F95100
FDA UDI
Class IActive
Custom Accessory D065
FDA UDI
Class IUnknown
Washington Connector 1785
FDA UDI
Class IActive
Adult Ultra Flex®anesthesia Breathing Circuit R61213F-6166Z
FDA UDI
Class IActive
Universal F® U260-61Z
FDA UDI
Class IActive
Pediatric Ultra Flex®anesthesia Breathing Circuit 2706B-13627
FDA UDI
Class IActive
Universal Flex2®breathing Circuit DF376R-6121Z
FDA UDI
Class IActive
Universal F® Flexbreathing Circuit FF375-61Z
FDA UDI
Class IActive
Universal F2®anesthesia Breathing Circuit NC365-6121Z
FDA UDI
Class IActive
Flex Connector 101057
FDA UDI
Class IActive
Adult Ultra Flex®anesthesia Breathing Circuit 8903F-28BZ
FDA UDI
Class IUnknown
Universal Flex2®breathing Circuit DF4110-6121Z
FDA UDI
Class IActive
Adult Ultra Flex®anesthesia Breathing Circuit 8753F-136Z
FDA UDI
Class IActive
Custom Accessory D022
FDA UDI
Class IActive
Breathing Bag 5105
FDA UDI
Class IActive
Universal Flex2®breathing Circuit DF475-6121Z
FDA UDI
Class IActive
Universal F® Flex2® AF475-17621Z
FDA UDI
Class IActive
Adult Ultra Flex®anesthesia Breathing Circuit R6613F-26Z
FDA UDI
Class IUnknown
Jackson Rees 3771-WSNZ
FDA UDI
Class IActive
Universal Flex2®breathing Circuit DFP170-6121
FDA UDI
Class IActive
Adult Anesthesia 8600B-61
FDA UDI
Class IActive
Universal F2® C360-61Z
FDA UDI
Class IActive
Universal Flex2® KNDF3116-6121Z
FDA UDI
Class IActive
Ped F2® Pediatricanesthesia Breathing Circuit PDY140-6133
FDA UDI
Class IUnknown
Universal Flex2®breathing Circuit DF375-618Z
FDA UDI
Class IActive
Universal Flex2®breathing Circuit KNCF3115-61Z
FDA UDI
Class IActive
Jackson Rees 3741P
FDA UDI
Class IActive
18" Reusable Tubing MD124
FDA UDI
Class IActive
Ped F2® Pediatricanesthesia Breathing Circuit PD060-6121
FDA UDI
Class IActive
Universal F® Flex2® AF3115-61Z
FDA UDI
Class IActive
Pediatric Ultra Flex®anesthesia Breathing Circuit 2616P-13221
FDA UDI
Class IActive
Universal Flex2®breathing Circuit & Pack Kit F94945
FDA UDI
Class IUnknown
Universal F2® XF20
FDA UDI
Class IActive
Pediatric Anesthesia 2502Y-6121
FDA UDI
Class IActive
SAMPLING LINE, 10ft, Co/Ext, M/F 7031
FDA UDI
Class IActive
Adult Ultra Flex®anesthesia Breathing Circuit J8753F-6121Z
FDA UDI
Class IActive
Universal Flex2®breathing Circuit & Pack Kit F90689
FDA UDI
Class IActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Feb 17, 2015Z-1361-2015—terminated

Product is mislabeled as Double Swivel Connector with Suction Port and is actually Double Swivel Connector without Suction port. If the incorrect component is not identified prior to clinical use, the incorrect connector would be replaced during the case without risk to the patient and could result in a short delay of the procedure.

Sep 3, 2013Z-2255-2013—terminated

Report that size 5 KLTD airways were packaged in pouches indicating a size of 2.5 and shipped to your facility. The correct size of the KLTD airway is clearly marked on the actual airway product and the physical size difference between 2.5 and 5 is distinct and obvious.

Nov 2, 2012Z-0426-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0420-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0421-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0418-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0419-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0425-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0427-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0423-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0424-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Nov 2, 2012Z-0422-2013—terminated

The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO

Aug 23, 2012Z-2272-2013—terminated

King Systems received a customer complaint indicating that the customer had ordered a breathing circuit with a Latex breathing bag. The product they received contained a Latex breathing bag, but was labeled as non-latex.

Jan 24, 2011Z-1889-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1879-2011—terminated

The firms contract manufacturer reported that the products were below the specification for hardness. This could contribute to a higher incidence of problems during the insertion and final positioning of the airway in the patient. In rare instances the softness of the tube could cause the tube to fold over.

Jan 24, 2011Z-1888-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1890-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1887-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1892-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 24, 2011Z-1878-2011—terminated

The firms contract manufacturer reported that the products were below the specification for hardness. This could contribute to a higher incidence of problems during the insertion and final positioning of the airway in the patient. In rare instances the softness of the tube could cause the tube to fold over.

Jan 24, 2011Z-1891-2011—terminated

The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.

Jan 14, 2011Z-1718-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1706-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1714-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1720-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1721-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1707-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1710-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1717-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1713-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1712-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1705-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1708-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1715-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1709-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1719-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1716-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Jan 14, 2011Z-1711-2011—terminated

King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca

Dec 15, 2009Z-0978-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0986-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0975-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0980-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0976-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0982-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0984-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0985-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0983-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0974-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0977-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0981-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Dec 15, 2009Z-0979-2011—terminated

King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat

Aug 1, 2008Z-0789-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0745-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0795-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0809-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0730-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0794-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0721-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0757-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0691-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0701-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0804-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0813-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0685-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0687-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0729-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0734-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0758-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0807-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0696-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0699-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0783-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0816-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0709-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0700-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0714-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0689-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0805-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0812-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0742-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0748-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0796-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0782-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0790-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0736-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0800-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0724-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0683-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0761-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0814-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0682-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0679-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0764-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0681-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0773-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0722-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0740-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0752-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0772-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.

Aug 1, 2008Z-0785-2009—terminated

The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.